Ticker

6/recent/ticker-posts

Advertisement

Responsive Advertisement

Transcatheter Heart Valve Replacement Market will be 8 Billion by 2025 - Renub Research

In the past few years global transcatheter heart valve replacement market has emerged as one of the best investment sector in the medical device field. Primarily due to more number of patients are opting for surgical and minimally invasive replacements. According to American heart association, valvular diseases are rising at an alarming rate among the geriatric population as they are more susceptible to cardiovascular and other chronic diseases. Transcatheter heart valve is the new invention in the medical field and its getting popular day by day since it has several advantages over open heart surgery.



The global heart valve replacement demand for Transcatheters is projected to emerge as one of the most lucrative investment opportunities in the years to come. As in the geriatric population, Transcatheter heart valve is the new treatment technology and becomes prominent year by year as it has many benefits over open heart surgery. Transcatheter Heart Valve Replacement Market is expected to be 8 Billion by the end of year 2025.

Repair of the Transcatheter aortic valve is a minimally invasive procedure. This technique is used without removing it to treat or restore old and damaged aortic valve. The technique used to insert a new valve to the place of the old aortic valve is called the Transcatheter aortic valve replacement system. Between the left atrium and the left ventricle is the mitral valve. Mitral valve disorder is a condition in which the valve ceases working properly, leading to abnormal blood flow. This abnormal blood flow can lead to diseases such as prolapse of the mitral valve and regurgitation of the mitral valve.

The major factors responsible for the boost of market are; Increased Valvular disease prevalence, adoption rate of minimally invasive technique are growing drastically, advanced level of Transcatheter devices, increasing healthcare per capita expenditure, rising awareness regarding the Transcatheter devices, success rate is quite high as compared to conventional procedure, the devices are now available in developing countries, increasing R&D expenditure, various companies launching innovative Transcatheter product etc.


About Us:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.


Contact Us
Renub Research
Phone: +1-678-302-0700
Website: www.renub.com

Post a Comment

0 Comments